Business Context and Reporting Period
Company: eHealth, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 17, 2021
Event: Entry into a Material Definitive Agreement for a private placement of Series A Preferred Stock.
Key Financial Metrics and Transaction Details
This filing details a capital raise rather than operational financial results. Key transaction metrics include:
- Investment Amount: $225,000,000 aggregate purchase price.
- Security Issued: 2,250,000 shares of newly designated Series A Preferred Stock.
- Price Per Share: $100 Stated Value.
- Dividend Rate: 8% per annum initially (Pay-In-Kind/PIK), compounding semiannually. After the second anniversary, the rate shifts to 6% PIK and 2% cash.
- Investor: Echelon Health SPV, LP (an affiliate of H.I.G. Capital).
Material Changes and Covenants
The Investment Agreement imposes significant operational and financial covenants on eHealth, Inc. until closing or termination:
- Asset Coverage Ratio: Must maintain a ratio of at least 2x (increasing to 2.5x after 30 months), defined as commissions receivable divided by Accrued Value plus funded indebtedness.
- Liquidity Requirements: Must maintain minimum average liquidity thresholds (generally $125 million for three consecutive months or $75 million for any single month, with adjustments based on stock price).
- Restrictions: The Company is restricted from issuing new equity, repurchasing stock, paying dividends, incurring significant indebtedness, or entering into material asset sales/contracts without Investor consent.
- Board Rights: The Investor gains the right to nominate one director if they hold at least 30% of the convertible common stock. Additional board seats and approval rights over the CEO/CFO and budget trigger if liquidity or asset coverage covenants are breached.
Conversion and Redemption Terms
- Conversion: Convertible after May 31, 2021. Initial conversion price is $90, subject to a reset mechanism on May 31, 2021, based on the 120-day VWAP following January 29, 2021 (capped between $50 and $90).
- Redemption Put: Investor may force redemption after the sixth anniversary at 135% of Accrued Value or conversion value, whichever is greater.
- Change of Control: Triggers a put right for the Investor to receive 135% of Accrued Value or conversion value.
Guidance, Outlook, and Risks
Closing Conditions: The transaction is subject to the expiration of the HSR Act waiting period, Nasdaq approval, and auditor independence confirmation. The agreement may be terminated if not closed by May 10, 2021.
Risks and Contingencies:
- Dilution: The conversion terms include complex anti-dilution and price reset mechanisms that could significantly impact common shareholders if the stock price rises substantially.
- Operational Control: Failure to meet liquidity or asset coverage ratios grants the Investor enhanced control, including the ability to approve the hiring/firing of key executives (CEO, CFO, CDO, CRO) and the annual budget.
- Forward-Looking Statements: The filing notes risks regarding the consummation of the deal and general economic conditions.
Investor Verification Checklist
- Verify the final closing date and whether all conditions (HSR, Nasdaq, Auditor) were satisfied.
- Monitor the Company's compliance with the Minimum Asset Coverage Ratio and Minimum Liquidity Amount thresholds to assess potential loss of management autonomy.
- Review the May 31, 2021 conversion price reset calculation to understand the potential dilution impact on common stock.
- Confirm the impact of the 8% PIK dividend on the Company's balance sheet and future cash flow obligations.
- Check for any subsequent filings regarding the appointment of the Investor's board nominee.